Literature DB >> 6836237

The mortality and causes of death of patients with "hypergamma type" of ankylosing spondylitis.

K Lehtinen.   

Abstract

The mortality and causes of death of 64 patients with ankylosing spondylitis (AS) were investigated. The mean follow-up time was 30 years. Eighteen patients had hypergammaglobulinaemia (serum gammaglobulin level less than 23.6 milligrams). A total of 36 deaths occurred during the follow-up time, 13 in the hypergammaglobulinaemia group and 23 in the control group. Six patients in the hypergammaglobulinaemia group and three in the control group died from uraemia caused by renal amyloidosis. The difference was statistically significant (p less than 0.01). It seems that hypergammaglobulinaemia may be a bad prognostic sign, at least when possible renal amyloidosis and uraemia are concerned.

Entities:  

Mesh:

Year:  1983        PMID: 6836237     DOI: 10.3109/03009748309101994

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  4 in total

Review 1.  Systemic amyloidosis: a challenge for the rheumatologist.

Authors:  Federico Perfetto; Alberto Moggi-Pignone; Riccardo Livi; Alessio Tempestini; Franco Bergesio; Marco Matucci-Cerinic
Journal:  Nat Rev Rheumatol       Date:  2010-06-08       Impact factor: 20.543

2.  Mortality in patients with ankylosing spondylitis in Argentina.

Authors:  Emilio Andres Buschiazzo; Emilce Edith Schneeberger; Fernando Andres Sommerfleck; Cesar Ledesma; Gustavo Citera
Journal:  Clin Rheumatol       Date:  2016-07-04       Impact factor: 2.980

3.  Frequency of fragmented QRS in ankylosing spondylitis : a prospective controlled study.

Authors:  A Inanir; K Ceyhan; S Okan; H Kadi
Journal:  Z Rheumatol       Date:  2013-06       Impact factor: 1.372

4.  The Gamma Gap and All-Cause Mortality.

Authors:  Stephen P Juraschek; Alison R Moliterno; William Checkley; Edgar R Miller
Journal:  PLoS One       Date:  2015-12-02       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.